Figure 1. Study Flow Diagram
[ATTACH=full]38605[/ATTACH]
All randomized participants who could be classified as having anemia or not having anemia at baseline and met the eligibility criteria for the parent trial, as well as the anemia study, were included in the analysis. As this was an event-driven trial and the trial design required the participants to be followed up until the accrual of 256 adjudicated major adverse cardiovascular events. Participants were considered in the study if their last visit date in the trial database fell within or after the defined visit window. All randomized participants were included in the primary and secondary analyses if they had at least 1 postbaseline hemoglobin value.
